Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

MAR 99

Known as: MAR-99 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
2001
2001
The aim of this study is to define the putative role of complement activation and mucosal mast cell (MMC) degranulation in the… Expand
  • figure 1
  • figure 3
  • figure 2
1998
1998
OBJECTIVES In this study, we determined the role of mucosal mast cell (MMC) activation in the pathogenesis of intestinal… Expand
1996
1996
To clarify the anti-gastric acid secretory mechanism of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarbo xylic… Expand
1996
1996
To disclose the cytoprotective mechanism of 1,6-dihydro-2[2-(2-methyoxypropoxy)anilino]-6-oxo-5-pyrimidinecarb oxylic acid (CAS… Expand
1994
1994
1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarbo xylic acid, (MAR-99, CAS 98772-05-5) (10-30 mg/kg i.g… Expand
1994
1994
The effects of 1,6-dihydro-2-[2-(2-methylpropoxy) anilino]-6-oxo-5-pyrimidinecarboxylic acid (MAR-99, CAS 98772-05-5) on various… Expand
1989
1989
Repeated intraperitoneal administration of compound 48/80 to rats produced gastric lesions, a decrease in connective tissue mast… Expand